fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Polyvinyl alcohol

All products: Limited Use (codes 49)

Liquifilm Tears · DIN 00045616 · 1.4% · Oph-Sol

Limited Use, Reason for Use code 49 required; Health Canada lists this DIN as Cancelled post market since 2011-08-04 — choose a marketed DIN from the same-category list.Discontinued August 4, 2011 · checked October 5, 2026
StatusLimited Use, Reason for Use code 49 required; Health Canada lists this DIN as Cancelled post market since 2011-08-04 — choose a marketed DIN from the same-category list.
Write on scriptReason for Use code 49 (criteria below); Health Canada lists this DIN as Cancelled post market since 2011-08-04 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 49
Reason for Use code 49 For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Liquifilm Tears · DIN 00045616 Manufacturer: Allergan Inc.; listing date 1996-10-01 Health Canada: Cancelled post market since 2011-08-04 · brand LIQUIFILM TEARS · ATC S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. · form Drops · route Ophthalmic · ingredients POLYVINYL ALCOHOL 1.4 % · company Allergan inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Liquifilm Tears: Formulary list price $0.64 per unit (the source does not state the unit; exact figure $0.6373). What the ministry pays, not the patient.

Ministry pays: $0.6373 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00045616)

Source record
DIN 00045616: Liquifilm Tears Raw flags: sec12=Y, sec3=Y Item: 523600069; group id 637; item number 1609; lccId 00093; manufacturer id ALL Source form: Oph-Sol; strength: 1.4% Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $0.6373; ministry $0.6373 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00045616 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2299
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00045616
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since August 4, 2011 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (S01XA): coverage varies; not interchangeable

  • Dextran + hydroxypropyl methylcellulose + polyquad (Tears Naturale II): limited Use
  • Methylcellulose (Isopto Tears): limited Use
  • Mineral oil + petrolatum (Lacri-Lube): limited Use

Polyvinyl alcohol & polyvinylpyrrolidone

All products: Limited Use (codes 49)

Tears Plus · DIN 00579408 · · Oph-Sol

Limited Use, Reason for Use code 49 required; Health Canada lists this DIN as Cancelled post market since 2025-02-21 — choose a marketed DIN from the same-category list.Discontinued February 21, 2025 · checked October 5, 2026
StatusLimited Use, Reason for Use code 49 required; Health Canada lists this DIN as Cancelled post market since 2025-02-21 — choose a marketed DIN from the same-category list.
Write on scriptReason for Use code 49 (criteria below); Health Canada lists this DIN as Cancelled post market since 2025-02-21 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 49
Reason for Use code 49 For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Tears Plus · DIN 00579408 Manufacturer: Allergan Inc.; listing date 1996-10-01 Health Canada: Cancelled post market since 2025-02-21 · brand TEARS PLUS · ATC S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. · form Solution · route Ophthalmic · ingredients POLYVINYL ALCOHOL 1.4 %/W/V · company Abbvie corporation · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Tears Plus: Formulary list price $0.38 per unit (the source does not state the unit; exact figure $0.3840). What the ministry pays, not the patient.

Ministry pays: $0.3840 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00579408)

Source record
DIN 00579408: Tears Plus Raw flags: sec12=Y, sec3=Y Item: 523600075; group id 638; item number 1610; lccId 00092; manufacturer id ALL Source form: Oph-Sol; strength: None Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $0.3840; ministry $0.3840 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00579408 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5121
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00579408
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since February 21, 2025 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (S01XA): coverage varies; not interchangeable

  • Dextran + hydroxypropyl methylcellulose + polyquad (Tears Naturale II): limited Use
  • Methylcellulose (Isopto Tears): limited Use
  • Mineral oil + petrolatum (Lacri-Lube): limited Use
Other drugs in the same formulary class (52:36 Other Eye, Ear, Nose and Throat Agents) and how they are covered

Matched class: 52:36 Other Eye, Ear, Nose and Throat Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BETAXOLOL HCL, DICLOFENAC SODIUM, LEVOBUNOLOL HCL Some products covered without a code (check the product listing): ACETAZOLAMIDE, METHAZOLAMIDE, SODIUM CROMOGLYCATE, TIMOLOL MALEATE 52:36 Other Eye, Ear, Nose and Throat Agents

DEXTRAN 70 & HYDROXYPROPYL METHYLCELLULOSE & POLYQUAD

· 1 products · Limited Use, codes 49 · strengths: 0.1%/0.3%/0.001% · Oph Sol

METHYLCELLULOSE

· 2 products · Limited Use, codes 49 · strengths: 0.5%, 1% · Oph Sol, Oph-Sol

PETROLATUM/MINERAL OIL

· 2 products · Limited Use, codes 49 · strengths: 55% & 42.5%, 80%/20% · Oph Oint-3.5g Pk

ACETAZOLAMIDE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 250mg · Tab

BETAXOLOL HCL

· 1 products · General benefit · strengths: 0.25% · Oph Susp

DICLOFENAC SODIUM

· 6 products · General benefit · strengths: 0.1% · Oph Sol

LEVOBUNOLOL HCL

· 1 products · General benefit · strengths: 0.5% · Oph Sol

METHAZOLAMIDE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 50mg · Tab

SODIUM CROMOGLYCATE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 2% · Oph Sol

TIMOLOL MALEATE

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 0.25%, 0.5% · Oph Gellan Sol, Oph Sol

AFLIBERCEPT

· 6 products · Limited Use, codes 729, 730, 731 (4), Limited Use, codes 694, 695 (2) · strengths: 2mg/0.05mL, 8mg/0.07mL · Inj Sol-0.05mL Pref Syr (Preservative-Free), Inj Sol-0.07mL Pref Syr, Inj Sol-0.07mL Vial Pk, Sol for Intravitreal Inj-0.05mL Vial Pk

BIMATOPROST

· 8 products · Listed, not a benefit (1), Limited Use, codes 171, 172, 387 (7) · strengths: 0.03%, 0.01% · Oph Sol, Oph Sol-5mL Pk, Oph Sol-7.5mL Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 52:36 and 19 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:08 Anti-Inflammatory Agents, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found